When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
INVVY - Indivior's Sublocade shows sustained benefit in opioid use disorder study
Indivior PLC ADR
Results from a Phase 3 clinical trial, RECOVER, evaluating Indivior PLC's (OTCPK:INVVY) SUBLOCADE (buprenorphine extended-release), administered via subcutaneous injection once per month, in patients with severe opioid use disorder (OUD) showed a sustained treatment benefit. The data were presented at the American Society of Addiction Medicine Annual Conference in Orlando.
More news on: Indivior PLC, Healthcare stocks news,